Importance of psychiatric examination in predictive genetic testing for Huntington disease;Znaczenie badania psychiatrycznego w predykcyjnych badaniach genetycznych w kierunku choroby Huntingtona

Neurologia i Neurochirurgia Polska

Volumn 47, Issue 6, 2013, Pages 534-541

  Uhrová, Tereza ^a   Židovská, Jana ^a   Koblihová, Jana ^b   Klempíř, Jiří ^a   Majerová, Veronika ^a   Roth, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CENTRAL MILITARY HOSPITAL   (Czech Republic)

Author keywords

Huntington disease; People at risk; Predictive genetic test

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; EYSENCK PERSONALITY QUESTIONNAIRE; FEMALE; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; NEUROSIS; POPULATION RISK; PREDICTION; PSYCHIATRIC DIAGNOSIS; PSYCHOMETRY; QUALITY OF LIFE; QUALITY OF LIFE QUESTIONNAIRE; QUESTIONNAIRE; SYMPTOM CHECKLIST 90;

EID: 84890066799     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2013.39070     Document Type: Article

References (32)

1. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
2. Tibben A. Predictive testing for Huntington's disease. Brain Res Bull 2007; 72: 165-171.
3. Robins Wahlin T.B. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease. Patient Educ Couns 2007; 65: 279-287.
4. International Huntington Association (IHA) and the World Fe-deration of Neurology (WFN) Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 1994; 44: 1533-1536.
5. Almqvist E.W., Brinkman R.R., Wiggins S., et al. Canadian Collaborative Study of Predictive Testing. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clin Genet 2003; 64: 300-309.
6. Tibben A., Duivenvoorden H.J., Niermeijer M.F., et al. Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosom Med 1994; 56: 526-532.
7. Decruyenaere M., Evers-Kiebooms G., Boogaerts A., et al. Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants. Genet Couns 1995; 6: 1-13.
8. Decruyenaere M., Evers-Kiebooms G., Boogaerts A., et al. Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. J Med Genet 1996; 33: 737-743.
9. Decruyenaere M., Evers-Kiebooms G., Cloostermans T., et al. Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur J Hum Genet 2003; 11: 30-38.
10. Almqvist E.W., Bloch M., Brinkman R., et al. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999; 64: 1293-1304.
11. Timman R., Roos R., Maat-Kievit A., et al. Adverse effects of predictive testing for Huntington disease underestimated: longterm effects 7-10 years after the test. Health Psychol 2004; 23: 189-197.
12. Licklederer C., Wolff G., Barth J. Mental health and quality of life after genetic testing for Huntington disease: a longterm effect study in Germany. Am J Med Genet 2008; 146A: 2078-2085.
13. Gargiulo M., Lejeune S., Tanguy M.L., et al. Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet 2009; 17: 165-171.
14. Dufrasne S., Roy M., Galvez M., et al. Experience over fifteen years with a protocol for predictive testing for Huntington disease. Mol Genet Metab 2011; 102: 494-504.
15. Taylor S.D. Demand for predictive genetic testing for Huntington's disease in Australia, 1987 to 1993. Med J Aust 1994; 161: 351, 354-355.
16. Laccone F., Engel U., Holinski-Feder E., et al. DNA analysis of Huntington's disease: five years of experience in Germany, Austria, and Switzerland. Neurology 1999; 53: 801-806.
17. Maat-Kievit A., Vegter-van der Vlis M., Zoeteweij M., et al. Paradox of a better test for Huntington's disease. J Neurol Neurosurg Psychiatry 2000; 69: 579-583.
18. Harper P.S., Lim C., Craufurd D. Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium. J Med Genet 2000; 37: 567-571.
19. Goizet C., Lesca G., Dürr A. French Group for Presymptomatic Testing in Neurogenetic Disorders. Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology 2002; 59: 1330-1336.
20. Creighton S., Almqvist E.W., MacGregor D., et al. Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clin Genet 2003; 63: 462-475.
21. Tassicker R.J., Teltscher B., Trembath M.K., et al. Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet 2009; 17: 66-70.
22. Eysenck H.J., Eysenck S.B. Manual of the Eysenck Personality Questionare. Hodder and Stoughton, London 1975.
23. Derogatis L.R., Lipman R.S., Covi L. SCL-90: Self-Report Symptom Inventory. In: Guy W. ECDEU Assessment Manual for Psychopharmacology. Rev. ed. DHEW, Rockville 1976, pp. 313-331.
24. Priebe S., Hugsley P., Knight S., et al. Aplication and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry 1999; 45: 7-12.
25. Evers-Kiebooms G., Decruyenaere M. Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals. Patient Educ Couns 1998; 35: 15-26.
26. Duff K., Paulsen J.S., Beglinger L.J., et al. Predict-HD Investigators of the Huntington Study Group. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry 2007; 62: 1341-1346.
27. Beglinger L.J., O'Rourke J.J., Wang C., et al.; Huntington Study Group Investigators. Earliest functional declines in Huntington disease. Psychiatry Res 2010; 178: 414-418.
28. Codori A.M., Brandt J. Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet 1994; 54: 174-184.
29. Wahlin T.B., Lundin A., Bäckman L., et al. Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status. Am J Med Genet 1997; 73: 356-365.
30. Bird T.D. Outrageous fortune: the risk of suicide in genetic testing for Huntington disease. Am J Hum Genet 1999; 64: 1289-1292.
31. Meiser B., Dunn S. Psychological impact of genetic testing for Huntington's disease: an update of the literature. J Neurol Neurosurg Psychiatry 2000; 69: 574-578.
32. Decruyenaere M., Evers-Kiebooms G., Boogaerts A., et al. The com plexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. Eur J Hum Genet 2007; 15: 453-462.